Hooman Yari

Title	Fellow,Postdoctoral Research
Institution	University of Oklahoma Health Sciences Center
Department	Microbiology & Immunology
Address	BRC 317 975 NE 10th St Oklahoma City OK 73104
vCard	Download vCard

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Nilsson JB, Kaabinejadian S, Yari H, Kester MGD, van Balen P, Hildebrand WH, Nielsen M. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci Adv. 2023 11 24; 9(47):eadj6367. PMID: 38000035; PMCID: PMC10672173.

Citations: 4 Fields:
Sci Science
Translation:Humans
Nilsson JB, Kaabinejadian S, Yari H, Peters B, Barra C, Gragert L, Hildebrand W, Nielsen M. Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome. Commun Biol. 2023 Apr 21; 6(1):442. PMID: 37085710; PMCID: PMC10121683.

Citations: 12 Translation:Humans Cells
Castro A, Kaabinejadian S, Yari H, Hildebrand W, Zanetti M, Carter H. Subcellular location of source proteins improves prediction of neoantigens for immunotherapy. EMBO J. 2022 12 15; 41(24):e111071. PMID: 36314681; PMCID: PMC9753441.

Citations: 2 Fields:
Bio Biotechnology Mol Molecular Biology
Translation:Humans
Kaabinejadian S, Barra C, Alvarez B, Yari H, Hildebrand WH, Nielsen M. Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome. Front Immunol. 2022; 13:835454. PMID: 35154160.

Citations: 17 Fields:
All Allergy and Immunology
Translation:Humans Cells
Yari H, Gali H, Awasthi V. Nanoparticles for Targeting of Prostate Cancer. Curr Pharm Des. 2020; 26(42):5393-5413. PMID: 32693761.

Citations: 4 Fields:
Pha Pharmacology
Translation:Humans
Yari H, Nkepang G, Awasthi V. Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer. Materials (Basel). 2019 Mar 05; 12(5). PMID: 30841602.

Citations: 15
Rao G, Nkepang G, Xu J, Yari H, Houson H, Teng C, Awasthi V. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome. Front Chem. 2018; 6:392. PMID: 30280096.

Citations: 3
Rao G, Houson H, Nkepang G, Yari H, Teng C, Awasthi V. Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24. Am J Physiol Gastrointest Liver Physiol. 2018 08 01; 315(2):G318-G327. PMID: 29746173.

Citations: 3 Fields:
Gas Gastroenterology Phy Physiology
Translation:Animals
Raghuvanshi D, Nkepang G, Hussain A, Yari H, Awasthi V. Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC method. J Pharm Anal. 2017 Feb; 7(1):1-9. PMID: 29404012.

Citations: 6

Year	Publications
2016	1
2018	2
2019	1
2020	1
2022	2
2023	2

Yari's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (36)

Explore

Co-Authors (5)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors